Summary:
Evanston Premier Healthcare Research is conducting a 12 week study comparing an investigation medication to placebo as add on to current cholesterol lowering treatment. 9 site visits.
Qualified participants must be on a stable dose of a statin for at least 6 weeks prior to screening of one of the following:
- Simvastatin(Zocor)40 mg or higher
- rosuvastatin(Crestor) 10 mg or higher
- atorvastatin(Lipitor) 20 mg or higher
- pravastatin(pravachol) 40 mg or higher
Qualified Participants May Receive:
$450 if complete all visits, physical exams and study related medication at no cost.